This book aims to offer the accumulated fertile experience of treating drug-resistant epileptic patients collected over the past few decades, focusing on aspects of neurology, neurosurgery, emergency care, critical care medicine and basic medical research.
Refractory status epilepticus is one of the most common severe and acute diseases in neurology and neurocritical care; it is also the main cause of death in epileptic patients. In the context of prevention and treatment processes, it is not only necessary to terminate epileptic seizures, but to also address the disruption of the patient’s internal environment and provide critical life support. Effective treatment calls for multi-disciplinary support from neurology, neurosurgery, emergency care, critical care medicine, and other fields. Further, since the clinical features of epileptic seizure are not specific, it is necessary to differentiate it from other diseases that produce convulsions, disorders of consciousness, syncope, mental and behavioral disorders, myoclonus, etc., to avoid misdiagnosis. In this book, it comprehensively and systematically describes the basic knowledge as well as prevention and treatment tips, providing an invaluable reference resource for medical students and professionals in neurology, neurosurgery, emergency care and critical care medicine.
Epilepsy，status epilepticus，refractory status epilepticus.- Pathogenesis of refractory status epilepticus.- Brain damage caused by status epilepticus.- The clinical features of refractory status epilepticus in various conditions.- The application of electroencephalogram in status epilepticus.- The clinical practice of drugs commonly used in refractory status epilepticus.- The non-drug treatment of refractory status epilepticus.- Treatment strategies of refractory status epilepticus.- Complications of refractory status epilepticus and other matters needing attention.- Special cases of refractory status epilepticus.
Professor Xuefeng Wang is the director of the Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China; Member of Executive Committee of the International League Against Epilepsy (ILAE); Editor-in-Chief, Epilepsy open journal of ILAE; Vice president, China Association Against Epilepsy (CAAE).
Professor Shichuo Li is the Lifetime Honorary President of the China Association Against Epilepsy (CAAE); Chairman of the UN Consultative Committee on Life Science and Human Health (CCLH), China Association of Science and Technology (CAST).
This book aims to offer the accumulated fertile experience of treating drug-resistant epileptic patients collected over the past few decades, focusing on aspects of neurology, neurosurgery, emergency care, critical care medicine and basic medical research.
Refractory status epilepticus is one of the most common severe and acute diseases in neurology and neurocritical care; it is also the main cause of death in epileptic patients. In the context of prevention and treatment processes, it is not only necessary to terminate epileptic seizures, but to also address the disruption of the patient’s internal environment and provide critical life support. Effective treatment calls for multi-disciplinary support from neurology, neurosurgery, emergency care, critical care medicine, and other fields. Further, since the clinical features of epileptic seizure are not specific, it is necessary to differentiate it from other diseases that produce convulsions, disorders of consciousness, syncope, mental and behavioral disorders, myoclonus, etc., to avoid misdiagnosis. In this book, it comprehensively and systematically describes the basic knowledge as well as prevention and treatment tips, providing an invaluable reference resource for medical students and professionals in neurology, neurosurgery, emergency care and critical care medicine.
Specifically focuses on refractory status epilepticus
Describes in detail the diagnosis and treatment of refractory status epilepticus
Offers comprehensive, multi-disciplinary information
